DK1694242T3 - Fremgangsmåde til fremstilling af farmaceutiske 7-(2-trimethylsilylethyl)camptothecinpræparater - Google Patents
Fremgangsmåde til fremstilling af farmaceutiske 7-(2-trimethylsilylethyl)camptothecinpræparaterInfo
- Publication number
- DK1694242T3 DK1694242T3 DK04800502.9T DK04800502T DK1694242T3 DK 1694242 T3 DK1694242 T3 DK 1694242T3 DK 04800502 T DK04800502 T DK 04800502T DK 1694242 T3 DK1694242 T3 DK 1694242T3
- Authority
- DK
- Denmark
- Prior art keywords
- trimethylsilylethyl
- pharmaceutical
- preparation
- camptothecin
- preparations
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title 2
- -1 2-trimethylsilylethyl Chemical group 0.000 title 1
- KLWPJMFMVPTNCC-UHFFFAOYSA-N Camptothecin Natural products CCC1(O)C(=O)OCC2=C1C=C3C4Nc5ccccc5C=C4CN3C2=O KLWPJMFMVPTNCC-UHFFFAOYSA-N 0.000 title 1
- VSJKWCGYPAHWDS-FQEVSTJZSA-N camptothecin Chemical compound C1=CC=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 VSJKWCGYPAHWDS-FQEVSTJZSA-N 0.000 title 1
- 229940127093 camptothecin Drugs 0.000 title 1
- VSJKWCGYPAHWDS-UHFFFAOYSA-N dl-camptothecin Natural products C1=CC=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)C5(O)CC)C4=NC2=C1 VSJKWCGYPAHWDS-UHFFFAOYSA-N 0.000 title 1
- 238000000034 method Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US53015403P | 2003-12-17 | 2003-12-17 | |
| PCT/US2004/036191 WO2005060871A1 (en) | 2003-12-17 | 2004-11-01 | Pharmaceutical formulations of camptothecins and process for making same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1694242T3 true DK1694242T3 (da) | 2014-06-30 |
Family
ID=34710158
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04800502.9T DK1694242T3 (da) | 2003-12-17 | 2004-11-01 | Fremgangsmåde til fremstilling af farmaceutiske 7-(2-trimethylsilylethyl)camptothecinpræparater |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1694242B1 (enExample) |
| JP (2) | JP5654723B2 (enExample) |
| CN (1) | CN1893892B (enExample) |
| AU (1) | AU2004305494B2 (enExample) |
| CA (1) | CA2548078C (enExample) |
| DK (1) | DK1694242T3 (enExample) |
| MX (1) | MXPA06006710A (enExample) |
| WO (1) | WO2005060871A1 (enExample) |
| ZA (1) | ZA200604757B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GT200500310A (es) | 2004-11-19 | 2006-06-19 | Compuestos organicos | |
| SA06270147B1 (ar) | 2005-06-09 | 2009-12-22 | نوفارتيس ايه جي | عملية لتخليق 5-(مثيل–1h–إيميدازول–1-يل )–3-(ثلاثي فلـورو مثيل)–بنزامـين |
| CN100592871C (zh) * | 2008-03-14 | 2010-03-03 | 浙江林学院 | 一种杀虫剂组合物及其加工方法 |
| JP2015521190A (ja) * | 2012-05-24 | 2015-07-27 | インノファーマ，インコーポレイテッド | アプレピタント注射製剤 |
| CN102911197B (zh) * | 2012-10-19 | 2015-05-06 | 杭州海杭生物医药科技有限公司 | 喜树碱硅杂衍生物、含该衍生物的组合物及其用途 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW406020B (en) * | 1993-09-29 | 2000-09-21 | Bristol Myers Squibb Co | Stabilized pharmaceutical composition and its method for preparation and stabilizing solvent |
| US5726181A (en) * | 1995-06-05 | 1998-03-10 | Bionumerik Pharmaceuticals, Inc. | Formulations and compositions of poorly water soluble camptothecin derivatives |
| CA2262745C (en) * | 1996-08-19 | 2006-04-04 | Bionumerik Pharmaceuticals, Inc. | Highly lipophilic camptothecin derivatives |
| WO1998035940A1 (en) * | 1997-02-14 | 1998-08-20 | Bionumerik Pharmaceuticals, Inc. | Highly lipophilic camptothecin derivatives |
| US6057303A (en) * | 1998-10-20 | 2000-05-02 | Bionumerik Pharmaceuticals, Inc. | Highly lipophilic Camptothecin derivatives |
-
2004
- 2004-11-01 CN CN2004800377708A patent/CN1893892B/zh not_active Expired - Fee Related
- 2004-11-01 AU AU2004305494A patent/AU2004305494B2/en not_active Ceased
- 2004-11-01 MX MXPA06006710A patent/MXPA06006710A/es active IP Right Grant
- 2004-11-01 CA CA002548078A patent/CA2548078C/en not_active Expired - Fee Related
- 2004-11-01 EP EP04800502.9A patent/EP1694242B1/en not_active Expired - Lifetime
- 2004-11-01 WO PCT/US2004/036191 patent/WO2005060871A1/en not_active Ceased
- 2004-11-01 JP JP2006545626A patent/JP5654723B2/ja not_active Expired - Fee Related
- 2004-11-01 DK DK04800502.9T patent/DK1694242T3/da active
-
2006
- 2006-06-09 ZA ZA2006/04757A patent/ZA200604757B/en unknown
-
2012
- 2012-08-08 JP JP2012176425A patent/JP2012214509A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2012214509A (ja) | 2012-11-08 |
| ZA200604757B (en) | 2008-04-30 |
| EP1694242A1 (en) | 2006-08-30 |
| CA2548078C (en) | 2009-05-12 |
| JP2007514778A (ja) | 2007-06-07 |
| CN1893892A (zh) | 2007-01-10 |
| AU2004305494A1 (en) | 2005-07-07 |
| CA2548078A1 (en) | 2005-07-07 |
| CN1893892B (zh) | 2012-03-28 |
| AU2004305494B2 (en) | 2009-09-10 |
| EP1694242A4 (en) | 2011-11-02 |
| JP5654723B2 (ja) | 2015-01-14 |
| EP1694242B1 (en) | 2014-04-16 |
| WO2005060871A1 (en) | 2005-07-07 |
| MXPA06006710A (es) | 2006-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1353668T3 (da) | Fremgangsmåder til fremstillingen af farmaceutiske sammensætninger, der indeholder epothilonanaloger, til behandlingen af cancer | |
| DK1420759T3 (da) | Farmaceutiske sammensætninger til behandling af astma | |
| NO20042680L (no) | Fremgangsmater for fremstilling av O-demetylvenflaxine | |
| DK1381351T3 (da) | Fremgangsmåde til kontinuerlig fremstilling af inhalerbare medikamenter | |
| DK1165576T3 (da) | Fremgangsmåde til fremstilling af amin-platin-komplekser | |
| DK1309545T3 (da) | Fremgangsmåde til fremstilling af alkylarylsulfonater | |
| DK1601359T3 (da) | Væskeformige, farmaceutiske formuleringer af palonosetron | |
| DK1667967T3 (da) | Fremgangsmåde til fremstilling af 2-oxo-1-pyrrolidin-derivater | |
| DK1345939T3 (da) | Fremgangsmåde til fremstilling af sulfonamidsubstituerede imidazotriazinoner | |
| DK1456229T3 (da) | Fremgangsmåe til fremstilling af echinocandin-derivater | |
| NO20044814L (no) | Fremgangsmate for fremstilling av combretastaniner | |
| NO20035538D0 (no) | Fremgangsmåte for fremstilling av zaleplon | |
| DK1678135T3 (da) | Fremgangsm de til fremstilling af n-amino-substituerede hetorocykliske forbindelser | |
| DK1838683T3 (da) | Fremgangsmåde til fremstilling af [1,4,5]-oxadiazepinderivater | |
| DK1682541T3 (da) | Fremgangsmåde til fremstilling af tiotropiumsalte | |
| DK1292586T3 (da) | Fremgangsmåde til fremstilling af pyrazolopyrimidinoner | |
| DK1694242T3 (da) | Fremgangsmåde til fremstilling af farmaceutiske 7-(2-trimethylsilylethyl)camptothecinpræparater | |
| DK1511724T3 (da) | Fremgangsmåde til fremstilling af thioalkylaminderivater | |
| IL171789A (en) | Process for the preparation of 7-alkyl-10-hydroxy-20(s)-camptothecin | |
| IS7958A (is) | Aðferð til að framleiða metýl 2-dífenýlmetýlsúlfínýlasetat | |
| DK1294694T3 (da) | Fremgangsmåde til fremstilling af quinolinderivater | |
| DK1550439T3 (da) | Fremgangsmåde til fremstilling af faste dosisformer af desmopressin | |
| DK1159296T3 (da) | Fremgangsmåde til fremstilling af cyclo-(Asp-DPhe-NMeVal-Arg-Gly) | |
| DK1385512T3 (da) | Anvendelse af pyridoindolonderivater til fremstilling af anticancerlægemidler | |
| DK1685104T3 (da) | Fremgangsmåde til fremstilling af N-substituerede phthalomider |